Become a member

Cart (0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Renaissance Glendale Hotel and Spa

Mar 16, 2015 1:00 PM - Mar 18, 2015 4:30 PM

9495 W. Coyotes Boulevard, Glendale, AZ 85305

Medical & Scientific Communications 2015 Annual Forum

Back to Agenda

Session 7 Track D: Publication Reviews to Achieve Quality

Session Chair(s)

Eileen Girten, MS

Eileen Girten, MS

Director, Medical Writing

Pfizer Inc, United States

This session will share a pharmaceutical company manuscript, abstract, and poster publication quality review process. Details that make up the quality review elements as well as strategic thinking behind the process will be presented, along with associated pros and cons. Four different quality review segments will be addressed: writing, medical/scientific, statistics, and data integrity. The session will end with a panel discussion with topic experts that will allow for robust audience Q&A, participation, and sharing of ideas and concerns.

Learning Objective : At the conclusion of this session, participants should be able to:
• Identify key components of publication development process leading to quality disclosures
• Explain expectations for author, editor, and contributor reviewer contributions
• Discuss the strategic delivery and importance of different review types, including writing, medical, statistics, and data integrity quality reviews

Speaker(s)

David B. Clemow, PhD

Faculty

David B. Clemow, PhD

Eli Lilly and Company, United States

Advisor, Scientific Communications Information Strategy

Faculty

Peter M. Fairfield, MBA

Eli Lilly & Company, United States

Scientific Communications Consultant

Faculty

Scott Patton

Stanford University, United States

Clinical Trials Regulatory Manager

Darryl L'Heureux, PhD, MPharm, MSc

Faculty

Darryl L'Heureux, PhD, MPharm, MSc

Ambrx, Inc, United States

Director, Clinical Science, Medical Writing, and Publications

Robin Whitsell

Faculty

Robin Whitsell

Whitsell Innovations, Inc., United States

President

Have an account?